MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill replace chemo shots for some blood cancers?
Disease control Recruiting nowThis study is testing an experimental oral drug called ASTX030 (a combination of azacitidine and cedazuridine) for people with certain blood cancers like myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML). The drug is given a…
Matched conditions: MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo hopes to tame bone marrow cancer
Disease control Recruiting nowThis early-phase trial tests a new drug called iadademstat combined with a standard chemotherapy (azacitidine) in people with myelodysplastic syndrome (MDS), a bone marrow disorder. The main goal is to find the safest dose for future studies. About 12 adults with higher-risk MDS …
Matched conditions: MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to boost stem cell transplant success in older blood cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug venetoclax to standard chemotherapy (fludarabine and melphalan) before a donor stem cell transplant can improve outcomes for patients over 50 with acute myeloid leukemia or myelodysplastic syndrome. The study will compare …
Matched conditions: MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC